Y Intercept Hong Kong Ltd Acquires Shares of 47,111 InfuSystem Holdings, Inc. $INFU

Y Intercept Hong Kong Ltd acquired a new position in shares of InfuSystem Holdings, Inc. (NYSE:INFU) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 47,111 shares of the company’s stock, valued at approximately $294,000.

A number of other institutional investors have also modified their holdings of INFU. CWM LLC lifted its position in shares of InfuSystem by 1,160.1% during the second quarter. CWM LLC now owns 4,826 shares of the company’s stock worth $30,000 after purchasing an additional 4,443 shares during the last quarter. Jump Financial LLC bought a new position in InfuSystem during the 1st quarter worth approximately $58,000. Williams & Novak LLC acquired a new position in shares of InfuSystem in the 2nd quarter worth approximately $77,000. Virtu Financial LLC bought a new stake in shares of InfuSystem in the 1st quarter valued at approximately $86,000. Finally, Jane Street Group LLC acquired a new stake in shares of InfuSystem during the 1st quarter valued at approximately $96,000. Institutional investors and hedge funds own 71.13% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have commented on INFU shares. Roth Capital reaffirmed a “buy” rating and issued a $14.00 price objective (up previously from $13.00) on shares of InfuSystem in a report on Tuesday. Lake Street Capital started coverage on shares of InfuSystem in a report on Monday, September 22nd. They issued a “buy” rating and a $15.00 price target for the company. Finally, Zacks Research lowered shares of InfuSystem from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 6th. Two investment analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, InfuSystem currently has an average rating of “Buy” and an average target price of $14.50.

InfuSystem Stock Performance

INFU stock opened at $9.92 on Friday. InfuSystem Holdings, Inc. has a 1 year low of $4.61 and a 1 year high of $11.04. The stock has a market capitalization of $202.63 million, a price-to-earnings ratio of 165.36 and a beta of 1.80. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.59 and a current ratio of 1.98. The stock’s fifty day moving average is $10.06 and its two-hundred day moving average is $7.72.

Insiders Place Their Bets

In other InfuSystem news, Director Scott Shuda sold 5,752 shares of the business’s stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $9.67, for a total transaction of $55,621.84. Following the completion of the transaction, the director directly owned 94,000 shares of the company’s stock, valued at $908,980. The trade was a 5.77% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 11.40% of the stock is currently owned by corporate insiders.

InfuSystem Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.